novavax vaccine - Search News

Order byBest matchMost fresh

FDA approves Novavax COVID-19 vaccine

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.

· 21h · on MSN

· 2d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

AARP · 16h

Third COVID Vaccine Gets Approved for Adults 65 and Over

FDA approves Novavax COVID-19 shot but with unusual restrictions

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.

· 1d

· 15h

RFK Jr. pledged not to revamp US vaccine system, yet ‘massive’ changes are on the way

· 1d

Novavax secures FDA approval for Covid vaccine, but with unexpected limitations

Pharmalittle: We’re reading about Regeneron buying 23andMe, the Novavax Covid shot, and more

The deal would appear to bring to a close a dramatic series of events for 23andMe, which became a widely known consumer brand but suffered as a business.

STAT · 23h

· 1d

Novavax jumps as FDA clears COVID-19 vaccine

Becker's Hospital Review · 18h

FDA approves Novavax COVID-19 shot, adds restrictions

BioPharma Dive20h

Novavax’s COVID vaccine gets FDA approval, but with limits

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

19hon MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.

16h

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This comes after the Food and Drug Administration (FDA) approved the company’s COVID-19 vaccine,

Devdiscourse2d

Global Health Alert: From Bird Flu in Brazil to Promising HIV Vaccine Trials

Health-related headlines include Mexico's suspension of poultry imports from Brazil due to bird flu, promising results from new HIV vaccine trials, and the FDA's conditional approval of Novavax's COVID-19 vaccine.

4don MSN

FDA to issue new vaccine approval guidance amid questions over coronavirus shots

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”

22h

Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers

Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) on the exchange. The US Food and Drug Administration (FDA) approves Novavax's (NVAX) COVID-19 vaccine,